hydantoins has been researched along with HIV Coinfection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HJ; DeGoey, DA; Dekhtyar, T; Flosi, WJ; Grampovnik, DJ; Kempf, D; Klein, LL; Marsh, KC; Masse, S; Mo, HM | 1 |
Kataropoulou, A; La Regina, G; Maga, G; Piscitelli, F; Samuele, A; Silvestri, R; Viola, M; Zanoli, S | 1 |
Caldwell, CG; Carella, A; Carver, G; Chen, P; Danzeisen, R; DeMartino, JA; Emini, EA; Finke, PE; Gould, SL; Hazuda, D; Holmes, K; Kessler, J; Kim, D; Lineberger, J; MacCoss, M; Malkowitz, L; Miller, M; Mills, SG; Oates, B; Schleif, WA; Springer, MS; Wang, L | 1 |
3 other study(ies) available for hydantoins and HIV Coinfection
Article | Year |
---|---|
Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV.
Topics: Crystallography, X-Ray; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Imidazolidines; Lopinavir; Magnetic Resonance Spectroscopy; Mutation; Pyrimidinones; Structure-Activity Relationship | 2006 |
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Hydantoins; Kinetics; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones | 2009 |
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection.
Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; HIV Infections; HIV-1; Humans; Hydantoins | 2001 |